In this context, it is noteworthy that, in addition to cancer cells, CRC samples include fractions of additional cell types (e.g., immune cells and stromal cells) that could express variable levels of Smad7 and/or Stat3 mRNA, thus contributing to the RNA transcripts measured in such samples. This evidence concerns the gene SMAD7 and colorectal carcinoma.